Photonic Data Science

Background and Objective: White blood cells (WBCs) and their subpopulations play critical roles in detecting blood cancers due to their distinct biological and biochemical characteristics. Infrared (IR) spectroscopy offers a rapid, label-free, and non-destructive approach to probe molecular composition, making it a promising tool for biomedical diagnostics. The objective of this proof-of-principle study is to investigate the possibility of IR spectroscopy combined with chemometrics to differentiate leukemia from lymphoma, and to assess the capability of whole WBCs and their subpopulations in distinguishing the two diseases. Methods: We based our study on 21 pediatric patients including 11 leukemia and 10 lymphoma cases, with in total 86,016 IR spectra measured from whole WBCs and the subpopulations. Data pipeline was established, including steps of spectral preprocessing, classification, and data fusion. Particularly, data fusion was implemented via low-, middle-, and high-level strategies, with the aim of combining spectra from different cell types and investigating their capability of differentiating the two blood cancers. Results: The classification, both with and without data fusion, was benchmarked via the patient-wise cross- validation. A balanced accuracy of 80.0% was achieved based on IR spectra of whole WBCs. Further improvement was observed when combining whole WBCs and its subpopulations, with the best performance of 90.0% from combining whole WBCs and granulocytes with high-level data fusion strategy. The performance was observed consistent for both linear and nonlinear classifications based on linear discriminant analysis (LDA) and support vector machine (SVM), respectively. Conclusions: The results indicate the promising potential of IR spectroscopy of blood samples to distinguish leukemia and lymphoma with the help of chemometric approaches. Further, WBC subpopulations, particularly granulocytes, were proven to contain complementary information to whole WBCs for differentiating leukemia from lymphoma. This provides critical insights for biomedical practice in blood cancer diagnostics.